|
US20100151556A1
(en)
*
|
2002-03-15 |
2010-06-17 |
Cellectis |
Hybrid and single chain meganucleases and use thereof
|
|
WO2009095742A1
(en)
|
2008-01-31 |
2009-08-06 |
Cellectis |
New i-crei derived single-chain meganuclease and uses thereof
|
|
EP1485475B2
(en)
*
|
2002-03-15 |
2017-09-20 |
Cellectis |
Hybrid and single chain meganucleases and use thereof
|
|
WO2004067753A2
(en)
*
|
2003-01-28 |
2004-08-12 |
Cellectis |
Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
|
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
|
EP3222715A1
(en)
*
|
2003-08-08 |
2017-09-27 |
Sangamo BioSciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
WO2006097854A1
(en)
*
|
2005-03-15 |
2006-09-21 |
Cellectis |
Heterodimeric meganucleases and use thereof
|
|
WO2006097784A1
(en)
*
|
2005-03-15 |
2006-09-21 |
Cellectis |
I-crei meganuclease variants with modified specificity, method of preparation and uses thereof
|
|
WO2007034262A1
(en)
*
|
2005-09-19 |
2007-03-29 |
Cellectis |
Heterodimeric meganucleases and use thereof
|
|
CN102286456B
(zh)
|
2005-04-04 |
2014-04-30 |
拜尔作物科学公司 |
用于去除所选择dna序列的方法和手段
|
|
ES2602184T3
(es)
*
|
2005-10-18 |
2017-02-20 |
Precision Biosciences |
Meganucleasas diseñadas racionalmente con especificidad de secuencia y afinidad de unión a ADN alteradas
|
|
US20140010797A1
(en)
*
|
2005-10-18 |
2014-01-09 |
Duke University |
Fusion Molecules of Rationally-Designed DNA-Binding Proteins and Effector Domains
|
|
WO2007049095A1
(en)
*
|
2005-10-25 |
2007-05-03 |
Cellectis |
Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof
|
|
WO2007060495A1
(en)
*
|
2005-10-25 |
2007-05-31 |
Cellectis |
I-crei homing endonuclease variants having novel cleavage specificity and use thereof
|
|
WO2007093836A1
(en)
*
|
2006-02-13 |
2007-08-23 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof
|
|
CA2648030C
(en)
*
|
2006-03-27 |
2018-02-13 |
Children's Hospital & Regional Medical Center |
Compositions and methods comprising the use of cell surface displayed homing endonucleases
|
|
WO2007139982A2
(en)
*
|
2006-05-25 |
2007-12-06 |
Sangamo Biosciences, Inc. |
Methods and compositions for gene inactivation
|
|
WO2008010009A1
(en)
*
|
2006-07-18 |
2008-01-24 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof
|
|
WO2008037436A1
(en)
|
2006-09-28 |
2008-04-03 |
Bayer Bioscience N.V. |
Methods and means for removal of a selected dna sequence
|
|
AU2007320880A1
(en)
*
|
2006-11-14 |
2008-05-22 |
Cellectis |
Meganuclease variants cleaving a DNA target sequence from the HPRT gene and uses thereof
|
|
WO2008059317A1
(en)
*
|
2006-11-14 |
2008-05-22 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof
|
|
JP2010510222A
(ja)
*
|
2006-11-17 |
2010-04-02 |
シェーリング コーポレイション |
増殖性障害に対する併用療法
|
|
WO2008093152A1
(en)
*
|
2007-02-01 |
2008-08-07 |
Cellectis |
Obligate heterodimer meganucleases and uses thereof
|
|
AU2007347328B2
(en)
*
|
2007-02-19 |
2013-03-07 |
Cellectis |
LAGLIDADG homing endonuclease variants having novel substrate specificity and use thereof
|
|
WO2008102199A1
(en)
*
|
2007-02-20 |
2008-08-28 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the beta-2-microglobulin gene and uses thereof
|
|
CN101765661B
(zh)
|
2007-06-01 |
2014-08-06 |
索拉兹米公司 |
在微生物中生产油
|
|
SG182144A1
(en)
*
|
2007-06-01 |
2012-07-30 |
Omt Inc |
Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenic human idiotype antibodies
|
|
EP2183381A1
(en)
*
|
2007-06-01 |
2010-05-12 |
Buelow Research Enterprises Llc |
Compositions and methods for producing antibodies having human idiotypes in transgenic birds
|
|
EP2160467B1
(en)
|
2007-06-05 |
2015-10-28 |
Bayer CropScience NV |
Methods and means for exact replacement of target dna in eukaryotic organisms
|
|
AU2008263502A1
(en)
*
|
2007-06-06 |
2008-12-18 |
Cellectis |
Method for enhancing the cleavage activity of I-Crei derived meganucleases
|
|
EP2568048A1
(en)
|
2007-06-29 |
2013-03-13 |
Pioneer Hi-Bred International, Inc. |
Methods for altering the genome of a monocot plant cell
|
|
WO2009013559A1
(en)
*
|
2007-07-23 |
2009-01-29 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof
|
|
WO2009019528A1
(en)
*
|
2007-08-03 |
2009-02-12 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof
|
|
US9506120B2
(en)
|
2007-09-27 |
2016-11-29 |
Sangamo Biosciences, Inc. |
Rapid in vivo identification of biologically active nucleases
|
|
US11235026B2
(en)
|
2007-09-27 |
2022-02-01 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modulating PD1
|
|
US8563314B2
(en)
|
2007-09-27 |
2013-10-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for modulating PD1
|
|
EP2215223B1
(en)
|
2007-10-31 |
2013-05-01 |
Precision Biosciences, Inc. |
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
|
|
JP2011505809A
(ja)
*
|
2007-12-07 |
2011-03-03 |
プレシジョン バイオサイエンシズ，インク． |
ヒトゲノムのＤＮａｓｅ高感受性領域に見出される認識配列を有する合理的に設計されたメガヌクレアーゼ
|
|
WO2009074842A1
(en)
*
|
2007-12-13 |
2009-06-18 |
Cellectis |
Improved chimeric meganuclease enzymes and uses thereof
|
|
HRP20130703T1
(en)
|
2008-02-29 |
2013-09-30 |
Monsanto Technology, Llc |
Corn plant event mon87460 and compositions and methods for detection thereof
|
|
WO2009114321A2
(en)
|
2008-03-11 |
2009-09-17 |
Precision Biosciencs, Inc. |
Rationally-designed meganucleases for maize genome engineering
|
|
US20100071083A1
(en)
*
|
2008-03-12 |
2010-03-18 |
Smith James J |
Temperature-dependent meganuclease activity
|
|
WO2009146179A1
(en)
*
|
2008-04-15 |
2009-12-03 |
University Of Iowa Research Foundation |
Zinc finger nuclease for the cftr gene and methods of use thereof
|
|
AU2009241351A1
(en)
*
|
2008-04-28 |
2009-11-05 |
Precision Biosciences, Inc. |
Fusion molecules of rationally-designed DNA-binding proteins and effector domains
|
|
US9217155B2
(en)
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
|
AU2009271011B2
(en)
*
|
2008-07-14 |
2015-10-22 |
Precision Biosciences, Inc. |
Recognition sequences for I-Crei-derived meganucleases and uses thereof
|
|
CA2736336A1
(en)
*
|
2008-09-08 |
2010-03-11 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from a glutamine synthetase gene and uses thereof
|
|
EP2180058A1
(en)
*
|
2008-10-23 |
2010-04-28 |
Cellectis |
Meganuclease recombination system
|
|
KR101763878B1
(ko)
|
2008-11-28 |
2017-08-01 |
테라비아 홀딩스 인코포레이티드 |
종속영양성 미생물에서 맞춤 오일의 생성
|
|
US20110023145A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in autism spectrum disorders
|
|
US20110023148A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of addiction-related genes in animals
|
|
US20110023152A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of cognition related genes in animals
|
|
US20110023143A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of neurodevelopmental genes in animals
|
|
US20110023140A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Rabbit genome editing with zinc finger nucleases
|
|
US20110016543A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in inflammation
|
|
US20110023151A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of abc transporters
|
|
US20110016540A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of genes associated with trinucleotide repeat expansion disorders in animals
|
|
US20110023153A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in alzheimer's disease
|
|
US20110023156A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Feline genome editing with zinc finger nucleases
|
|
US20110023154A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Silkworm genome editing with zinc finger nucleases
|
|
US20110016546A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Porcine genome editing with zinc finger nucleases
|
|
US20110016539A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of neurotransmission-related genes in animals
|
|
US20110023141A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved with parkinson's disease
|
|
US20110016541A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of sensory-related genes in animals
|
|
US20110023149A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in tumor suppression in animals
|
|
US20110023144A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in amyotrophyic lateral sclerosis disease
|
|
US20110023147A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of prion disorder-related genes in animals
|
|
US20110030072A1
(en)
*
|
2008-12-04 |
2011-02-03 |
Sigma-Aldrich Co. |
Genome editing of immunodeficiency genes in animals
|
|
US20110023150A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of genes associated with schizophrenia in animals
|
|
US20110023158A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Bovine genome editing with zinc finger nucleases
|
|
US20110023139A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in cardiovascular disease
|
|
US20110023146A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in secretase-associated disorders
|
|
US20110239315A1
(en)
|
2009-01-12 |
2011-09-29 |
Ulla Bonas |
Modular dna-binding domains and methods of use
|
|
EP2206723A1
(en)
|
2009-01-12 |
2010-07-14 |
Bonas, Ulla |
Modular DNA-binding domains
|
|
US20110294217A1
(en)
*
|
2009-02-12 |
2011-12-01 |
Fred Hutchinson Cancer Research Center |
Dna nicking enzyme from a homing endonuclease that stimulates site-specific gene conversion
|
|
WO2010107493A2
(en)
|
2009-03-20 |
2010-09-23 |
Sangamo Biosciences, Inc. |
Modification of cxcr4 using engineered zinc finger proteins
|
|
WO2010122367A2
(en)
*
|
2009-04-21 |
2010-10-28 |
Cellectis |
Meganuclease variants cleaving the genomic insertion of a virus and uses thereof
|
|
US8772008B2
(en)
*
|
2009-05-18 |
2014-07-08 |
Sangamo Biosciences, Inc. |
Methods and compositions for increasing nuclease activity
|
|
WO2010136841A2
(en)
*
|
2009-05-26 |
2010-12-02 |
Cellectis |
Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof
|
|
WO2010136981A2
(en)
|
2009-05-26 |
2010-12-02 |
Cellectis |
Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof
|
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
|
EP2449135B1
(en)
|
2009-06-30 |
2016-01-06 |
Sangamo BioSciences, Inc. |
Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
|
|
WO2011007193A1
(en)
|
2009-07-17 |
2011-01-20 |
Cellectis |
Viral vectors encoding a dna repair matrix and containing a virion-associated site specific meganuclease for gene targeting
|
|
WO2011016840A2
(en)
|
2009-07-28 |
2011-02-10 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating trinucleotide repeat disorders
|
|
KR20120038020A
(ko)
*
|
2009-08-11 |
2012-04-20 |
상가모 바이오사이언스 인코포레이티드 |
표적화 변형에 대한 동형접합성 유기체
|
|
WO2011021062A1
(en)
|
2009-08-21 |
2011-02-24 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the human lysosomal acid alpha-glucosidase gene and uses thereof
|
|
WO2011036640A2
(en)
|
2009-09-24 |
2011-03-31 |
Cellectis |
Meganuclease reagents of uses thereof for treating genetic diseases caused by frame shift/non sense mutations
|
|
CN102639695B
(zh)
|
2009-10-26 |
2015-01-21 |
独立行政法人农业生物资源研究所 |
转基因植物细胞的制造方法
|
|
NO2510096T3
(enExample)
|
2009-12-10 |
2015-03-21 |
|
|
|
US8704041B2
(en)
|
2009-12-30 |
2014-04-22 |
Pioneer Hi Bred International Inc |
Methods and compositions for targeted polynucleotide modification
|
|
US20120329067A1
(en)
*
|
2010-01-22 |
2012-12-27 |
Barbas Iii Carlos F |
Methods of Generating Zinc Finger Nucleases Having Altered Activity
|
|
EP2531609A1
(en)
|
2010-02-02 |
2012-12-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the diagnosis and therapy of retinitis pigmentosa
|
|
US20130045492A1
(en)
|
2010-02-08 |
2013-02-21 |
Regeneron Pharmaceuticals, Inc. |
Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
|
|
ES2547142T5
(es)
|
2010-02-08 |
2021-12-09 |
Regeneron Pharma |
Cadena ligera común de ratón
|
|
US9796788B2
(en)
|
2010-02-08 |
2017-10-24 |
Regeneron Pharmaceuticals, Inc. |
Mice expressing a limited immunoglobulin light chain repertoire
|
|
WO2011101696A1
(en)
|
2010-02-18 |
2011-08-25 |
Cellectis |
Improved meganuclease recombination system
|
|
US20130227715A1
(en)
|
2010-02-26 |
2013-08-29 |
Cellectis |
Use of endonucleases for inserting transgenes into safe harbor loci
|
|
EP2550358A1
(en)
*
|
2010-03-22 |
2013-01-30 |
Philip Morris Products S.A. |
Modifying enzyme activity in plants
|
|
EP3540055A1
(en)
|
2010-04-23 |
2019-09-18 |
University of Massachusetts |
Cns targeting aav vectors and methods of use thereof
|
|
US9272053B2
(en)
|
2010-04-23 |
2016-03-01 |
University Of Massachusetts |
AAV-based treatment of cholesterol-related disorders
|
|
CA2833905C
(en)
|
2010-04-23 |
2019-09-10 |
University Of Massachusetts |
Multicistronic expression constructs
|
|
CA2799095A1
(en)
|
2010-05-12 |
2011-11-17 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the dystrophin gene and uses thereof
|
|
EP2569435A1
(en)
*
|
2010-05-12 |
2013-03-20 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the rhodopsin gene and uses thereof
|
|
CN103025344B
(zh)
|
2010-05-17 |
2016-06-29 |
桑格摩生物科学股份有限公司 |
新型dna-结合蛋白及其用途
|
|
JP5996527B2
(ja)
|
2010-05-28 |
2016-09-21 |
テラヴィア ホールディングス， インコーポレイテッド |
用途に応じた油を含む食品成分
|
|
US20140148361A1
(en)
*
|
2010-06-07 |
2014-05-29 |
Barry L. Stoddard |
Generation and Expression of Engineered I-ONUI Endonuclease and Its Homologues and Uses Thereof
|
|
WO2011154159A1
(en)
|
2010-06-09 |
2011-12-15 |
Bayer Bioscience N.V. |
Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
|
|
WO2011154158A1
(en)
|
2010-06-09 |
2011-12-15 |
Bayer Bioscience N.V. |
Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
|
|
GB201009732D0
(en)
|
2010-06-10 |
2010-07-21 |
Gene Bridges Gmbh |
Direct cloning
|
|
US20130196320A1
(en)
|
2010-06-15 |
2013-08-01 |
Cellectis |
Method for improving cleavage of dna by endonuclease sensitive to methylation
|
|
JP2013534423A
(ja)
|
2010-07-07 |
2013-09-05 |
セレクティス |
Ｎａｎｏｇ遺伝子中のｄｎａ標的配列を切断するメガヌクレアーゼバリアント及びその使用
|
|
WO2012010976A2
(en)
|
2010-07-15 |
2012-01-26 |
Cellectis |
Meganuclease variants cleaving a dna target sequence in the tert gene and uses thereof
|
|
WO2012007848A2
(en)
|
2010-07-16 |
2012-01-19 |
Cellectis |
Meganuclease variants cleaving a dna target sequence in the was gene and uses thereof
|
|
EP2412806B1
(en)
*
|
2010-07-28 |
2014-01-08 |
Institut Pasteur |
Use of terminal deoxynucleotidyl transferase for mutagenic DNA repair to generate variability, at a determined position in DNA
|
|
US9187762B2
(en)
|
2010-08-13 |
2015-11-17 |
Pioneer Hi-Bred International, Inc. |
Compositions and methods comprising sequences having hydroxyphenylpyruvate dioxygenase (HPPD) activity
|
|
SG189482A1
(en)
|
2010-10-27 |
2013-05-31 |
Cellectis |
Method for increasing the efficiency of double-strand break-induced mutagenesis
|
|
MX354145B
(es)
|
2010-11-03 |
2018-02-14 |
Terravia Holdings Inc |
Aceites microbianos con puntos de fluidez reducidos, fluidos dielectricos producidos a partir de estos y metodos relacionados.
|
|
AU2012212079B2
(en)
|
2011-02-02 |
2016-07-28 |
Corbion Biotech, Inc. |
Tailored oils produced from recombinant oleaginous microorganisms
|
|
US9044492B2
(en)
|
2011-02-04 |
2015-06-02 |
Cellectis Sa |
Method for modulating the efficiency of double-strand break-induced mutagenesis
|
|
AR085302A1
(es)
|
2011-02-24 |
2013-09-18 |
Sanofi Sa |
Metodo de produccion de anticuerpos sialilados
|
|
EP3603662B1
(en)
|
2011-02-28 |
2022-01-19 |
Seattle Children's Research Institute |
Coupling endonucleases with end-processing enzymes drive high efficiency gene disruption
|
|
US10030245B2
(en)
|
2011-03-23 |
2018-07-24 |
E I Du Pont De Nemours And Company |
Methods for producing a complex transgenic trait locus
|
|
WO2012138901A1
(en)
|
2011-04-05 |
2012-10-11 |
Cellectis Sa |
Method for enhancing rare-cutting endonuclease efficiency and uses thereof
|
|
KR101982360B1
(ko)
|
2011-04-05 |
2019-05-24 |
셀렉티스 |
콤팩트 tale-뉴클레아제의 발생 방법 및 이의 용도
|
|
US9226976B2
(en)
|
2011-04-21 |
2016-01-05 |
University Of Massachusetts |
RAAV-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
|
|
JP6158170B2
(ja)
|
2011-04-27 |
2017-07-12 |
アミリス， インコーポレイテッド |
ゲノム修飾のための方法
|
|
EP2704554B1
(en)
|
2011-05-02 |
2019-04-10 |
The Board of Regents of the University of Nebraska |
Plants with useful traits and related methods
|
|
US8846352B2
(en)
|
2011-05-06 |
2014-09-30 |
Solazyme, Inc. |
Genetically engineered microorganisms that metabolize xylose
|
|
WO2012158778A1
(en)
|
2011-05-16 |
2012-11-22 |
Cellectis S.A. |
Doubly secure transgenic algae or cyanobacteria strains to prevent their establishment and spread in natural ecosystems
|
|
WO2012167192A2
(en)
|
2011-06-01 |
2012-12-06 |
Precision Biosciences, Inc. |
Methods and products for producing engineered mammalian cell lines with amplified transgenes
|
|
US9540623B2
(en)
|
2011-07-08 |
2017-01-10 |
Cellectis |
Method for increasing the efficiency of double-strand-break induced mutagenesis
|
|
US9161995B2
(en)
*
|
2011-07-25 |
2015-10-20 |
Sangamo Biosciences, Inc. |
Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (CFTR) gene
|
|
IL273982B2
(en)
|
2011-08-05 |
2023-03-01 |
Regeneron Pharma |
Humanized mice possess a universal light chain
|
|
BR122014004140B8
(pt)
|
2011-08-22 |
2023-03-28 |
Bayer Cropscience Ag |
Vetor recombinante ou construção recombinante, bem como métodos para obter e produzir uma planta de algodão ou célula vegetal tolerante a um inibidor de hppd, e para cultivar um campo de plantas de algodão
|
|
BR112014008723A2
(pt)
|
2011-10-12 |
2019-09-24 |
Bayer Cropscience Ag |
plantas com diminuição da atividade de uma enzima de desforilação de àmido
|
|
BR112014008895A2
(pt)
|
2011-10-12 |
2019-09-24 |
Bayer Cropscience Ag |
plantas com atividade diminuída de uma enzima de desfosforilação do amido
|
|
CA2852955C
(en)
*
|
2011-10-27 |
2021-02-16 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of the hprt locus
|
|
CN104039967A
(zh)
|
2012-01-06 |
2014-09-10 |
先锋高级育种国际公司 |
筛选植物的在植物中诱导孤雌生殖的遗传元件的方法
|
|
SG10201606959PA
(en)
|
2012-02-24 |
2016-09-29 |
Hutchinson Fred Cancer Res |
Compositions and methods for the treatment of hemoglobinopathies
|
|
MX374399B
(es)
|
2012-02-29 |
2025-03-06 |
Sangamo Biosciences Inc |
Composiciones y sus usos para tratar y prevenir la enfermedad de huntington.
|
|
DK2825190T3
(en)
|
2012-03-15 |
2017-02-27 |
Cellectis |
REPEAT VARIABLE DIRESTS FOR TARGETING NUCLEOTIDES
|
|
SG11201405956SA
(en)
|
2012-03-23 |
2014-11-27 |
Cellectis |
Method to overcome dna chemical modifications sensitivity of engineered tale dna binding domains
|
|
SG11201406711TA
(en)
|
2012-04-18 |
2014-11-27 |
Solazyme Inc |
Tailored oils
|
|
US9719114B2
(en)
|
2012-04-18 |
2017-08-01 |
Terravia Holdings, Inc. |
Tailored oils
|
|
EP2841581B2
(en)
|
2012-04-23 |
2023-03-08 |
BASF Agricultural Solutions Seed US LLC |
Targeted genome engineering in plants
|
|
US20150017136A1
(en)
|
2013-07-15 |
2015-01-15 |
Cellectis |
Methods for engineering allogeneic and highly active t cell for immunotherapy
|
|
DK3473707T3
(da)
|
2012-05-25 |
2025-03-17 |
Cellectis |
Fremgangsmåder til engineering af allogen og immunsuppressiv resistent t-celle til immunoterapi
|
|
WO2013182910A2
(en)
|
2012-06-05 |
2013-12-12 |
Cellectis |
New transcription activator-like effector (tale) fusion protein
|
|
BR112014031891A2
(pt)
|
2012-06-19 |
2017-08-01 |
Univ Minnesota |
direcionamento genético nas plantas utilizando vírus de dna
|
|
US10648001B2
(en)
*
|
2012-07-11 |
2020-05-12 |
Sangamo Therapeutics, Inc. |
Method of treating mucopolysaccharidosis type I or II
|
|
CA2875618C
(en)
|
2012-07-11 |
2021-04-27 |
Sangamo Biosciences, Inc. |
Methods and compositions for the treatment of lysosomal storage diseases
|
|
US20140230083A1
(en)
|
2012-07-24 |
2014-08-14 |
Cellectis |
Modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins
|
|
JP6164696B2
(ja)
*
|
2012-08-16 |
2017-07-19 |
公立大学法人横浜市立大学 |
ミトコンドリア複合体ｉｉｉ欠乏症患者又は保因者の検出方法
|
|
EP2893016B1
(en)
|
2012-09-03 |
2019-06-19 |
Cellectis |
Methods for modulating tal specificity
|
|
WO2014039523A1
(en)
|
2012-09-04 |
2014-03-13 |
Cellectis |
Multi-chain chimeric antigen receptor and uses thereof
|
|
EP2906684B8
(en)
|
2012-10-10 |
2020-09-02 |
Sangamo Therapeutics, Inc. |
T cell modifying compounds and uses thereof
|
|
US20150291967A1
(en)
|
2012-10-31 |
2015-10-15 |
Luc Mathis |
Coupling herbicide resistance with targeted insertion of transgenes in plants
|
|
US20140120578A1
(en)
|
2012-11-01 |
2014-05-01 |
Medicago Inc. |
Plants for production of therapeutic proteins
|
|
US20150322152A1
(en)
|
2012-11-30 |
2015-11-12 |
Institut Pasteur |
Use of anti-fcyri and/or anti-fcyriia antibodies for treating arthritis, inflammation, thrombocytopenia and allergic shock
|
|
EP2934097B1
(en)
|
2012-12-21 |
2018-05-02 |
Cellectis |
Potatoes with reduced cold-induced sweetening
|
|
DK3491915T5
(da)
|
2012-12-27 |
2024-09-02 |
Keygene Nv |
Fremgangsmåde til at inducere en målrettet translokation i en plante
|
|
US20140199495A1
(en)
|
2013-01-11 |
2014-07-17 |
Floor Iptech Ab |
Digital printing and embossing
|
|
WO2014118719A1
(en)
|
2013-02-01 |
2014-08-07 |
Cellectis |
Tevl chimeric endonuclease and their preferential cleavage sites
|
|
US20150353885A1
(en)
|
2013-02-21 |
2015-12-10 |
Cellectis |
Method to counter-select cells or organisms by linking loci to nuclease components
|
|
US9777262B2
(en)
|
2013-03-13 |
2017-10-03 |
President And Fellows Of Harvard College |
Mutants of Cre recombinase
|
|
CN105246324B
(zh)
*
|
2013-03-15 |
2018-08-28 |
塞尔克蒂斯股份有限公司 |
通过靶向敲除fad2-1a/1b基因来改良大豆油成分
|
|
US10113162B2
(en)
*
|
2013-03-15 |
2018-10-30 |
Cellectis |
Modifying soybean oil composition through targeted knockout of the FAD2-1A/1B genes
|
|
WO2014184744A1
(en)
|
2013-05-13 |
2014-11-20 |
Cellectis |
Methods for engineering highly active t cell for immunotherapy
|
|
CN105531372A
(zh)
|
2013-06-14 |
2016-04-27 |
塞尔克蒂斯股份有限公司 |
植物中非转基因基因组编辑方法
|
|
CA3109801C
(en)
|
2013-08-22 |
2024-01-09 |
Andrew Cigan |
Plant genome modification using guide rna/cas endonuclease systems and methods of use
|
|
US10767188B2
(en)
|
2013-09-25 |
2020-09-08 |
Nutech Ventures |
Methods and compositions for obtaining useful plant traits
|
|
MX369685B
(es)
|
2013-10-04 |
2019-11-19 |
Terravia Holdings Inc |
Aceites adaptables.
|
|
CN105916983A
(zh)
|
2013-10-25 |
2016-08-31 |
塞勒克提斯公司 |
用于高效且特异性靶向包含高度重复基序的dna序列的稀有切割核酸内切酶的设计
|
|
EP3068905A4
(en)
|
2013-11-11 |
2017-07-05 |
Sangamo BioSciences, Inc. |
Methods and compositions for treating huntington's disease
|
|
AU2014368982B2
(en)
|
2013-12-19 |
2021-03-25 |
Amyris, Inc. |
Methods for genomic integration
|
|
MX386422B
(es)
|
2013-12-20 |
2025-03-18 |
Fred Hutchinson Cancer Center |
Moléculas efectoras químericas etiquetadas y receptores de las mismas.
|
|
DK3116533T3
(da)
*
|
2014-03-12 |
2020-08-24 |
Prec Biosciences Inc |
Deletion af dystrophingenexon under anvendelse af genmanipulerede nukleaser
|
|
EP3119878B1
(en)
|
2014-03-18 |
2021-05-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for regulation of zinc finger protein expression
|
|
JP6756700B2
(ja)
|
2014-03-18 |
2020-09-16 |
ユニバーシティ オブ マサチューセッツ |
筋萎縮性側索硬化症を処置するためのｒＡＡＶベースの組成物および方法
|
|
MX392639B
(es)
|
2014-03-21 |
2025-03-24 |
Univ Leland Stanford Junior |
Vectores virales recombinantes para la integración de transgenes
|
|
BR112016021572A2
(pt)
|
2014-03-21 |
2017-10-03 |
Regeneron Pharma |
Métodos para preparar um animal não humano geneticamente modificado e para produzir proteínas de ligação, hibridoma, ácido nucleico, célula, e, proteína de ligação
|
|
US10689653B2
(en)
|
2014-06-03 |
2020-06-23 |
University Of Massachusetts |
Compositions and methods for modulating dysferlin expression
|
|
EP3158072B1
(en)
|
2014-06-20 |
2021-01-13 |
Cellectis |
Potatoes with reduced granule-bound starch synthase
|
|
CN106574255A
(zh)
|
2014-07-10 |
2017-04-19 |
泰拉瑞亚控股公司 |
酮脂酰acp合酶基因及其用途
|
|
JP6842410B2
(ja)
|
2014-10-03 |
2021-03-17 |
ユニバーシティ オブ マサチューセッツ |
新規の高効率ライブラリーにより同定されるａａｖベクター
|
|
WO2016054554A1
(en)
|
2014-10-03 |
2016-04-07 |
University Of Massachusetts |
Heterologous targeting peptide grafted aavs
|
|
RU2738421C2
(ru)
|
2014-10-21 |
2020-12-14 |
Юниверсити Оф Массачусетс |
Варианты рекомбинантных aav и их применения
|
|
JP6827928B2
(ja)
|
2014-12-19 |
2021-02-10 |
ユニヴェルシテ・ドゥ・ナント |
抗ｉｌ−３４抗体
|
|
CN107709551A
(zh)
|
2015-02-02 |
2018-02-16 |
塞尔克蒂斯股份有限公司 |
无t‑dna整合的农杆菌介导的基因组修饰
|
|
WO2016131009A1
(en)
|
2015-02-13 |
2016-08-18 |
University Of Massachusetts |
Compositions and methods for transient delivery of nucleases
|
|
EP3271403A1
(en)
|
2015-03-19 |
2018-01-24 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals that select for light chain variable regions that bind antigen
|
|
EP3851530A1
(en)
*
|
2015-03-26 |
2021-07-21 |
Editas Medicine, Inc. |
Crispr/cas-mediated gene conversion
|
|
AU2016243052C1
(en)
|
2015-04-03 |
2022-11-24 |
Dana-Farber Cancer Institute, Inc. |
Composition and methods of genome editing of B-cells
|
|
US11046955B2
(en)
|
2015-04-24 |
2021-06-29 |
University Of Massachusetts |
Modified AAV constructs and uses thereof
|
|
US11827904B2
(en)
|
2015-04-29 |
2023-11-28 |
Fred Hutchinson Cancer Center |
Modified stem cells and uses thereof
|
|
ES2905181T3
(es)
|
2015-05-01 |
2022-04-07 |
Prec Biosciences Inc |
Deleción precisa de secuencias cromosómicas in vivo
|
|
WO2016178207A1
(en)
|
2015-05-04 |
2016-11-10 |
Ramot At Tel-Aviv University Ltd. |
Methods and kits for fragmenting dna
|
|
US20180119174A1
(en)
|
2015-05-13 |
2018-05-03 |
Seattle Children's Hospita (dba Seattle Children's Research Institute |
Enhancing endonuclease based gene editing in primary cells
|
|
US11193131B2
(en)
|
2015-06-30 |
2021-12-07 |
Regents Of The University Of Minnesota |
Haploid inducer line for accelerated genome editing
|
|
US20190024073A1
(en)
|
2015-07-23 |
2019-01-24 |
Mayo Foundation For Medical Education And Research |
Editing mitochondrial dna
|
|
EP3339437B1
(en)
*
|
2015-08-20 |
2021-11-17 |
Inter-University Research Institute Corporation Research Organization of Information and Systems |
Method for site-specific insertion of foreign dna into animal cell genome and cell obtained using same
|
|
US10837024B2
(en)
|
2015-09-17 |
2020-11-17 |
Cellectis |
Modifying messenger RNA stability in plant transformations
|
|
DK3364997T5
(da)
|
2015-10-22 |
2024-09-30 |
Univ Massachusetts |
Aspartoacylase genterapi til behandling af canavans sygdom
|
|
WO2017070516A1
(en)
|
2015-10-22 |
2017-04-27 |
University Of Massachusetts |
Prostate-targeting adeno-associated virus serotype vectors
|
|
WO2017079428A1
(en)
|
2015-11-04 |
2017-05-11 |
President And Fellows Of Harvard College |
Site specific germline modification
|
|
AU2016369490C1
(en)
|
2015-12-18 |
2021-12-23 |
Sangamo Therapeutics, Inc. |
Targeted disruption of the T cell receptor
|
|
JP2018537112A
(ja)
|
2015-12-18 |
2018-12-20 |
サンガモ セラピューティクス， インコーポレイテッド |
Ｍｈｃ細胞受容体の標的化破壊
|
|
NZ743983A
(en)
|
2016-01-11 |
2025-08-29 |
Univ Leland Stanford Junior |
Chimeric proteins and methods of regulating gene expression
|
|
EP3901258A1
(en)
|
2016-01-11 |
2021-10-27 |
The Board of Trustees of the Leland Stanford Junior University |
Chimeric proteins and methods of immunotherapy
|
|
EP3411059A4
(en)
|
2016-02-02 |
2019-10-16 |
University Of Massachusetts |
METHOD FOR INCREASING THE EFFECTIVENESS OF THE SYSTEMIC DELIVERY OF AVV GENES TO THE CENTRAL NERVOUS SYSTEM
|
|
EP4646936A3
(en)
|
2016-02-02 |
2025-11-19 |
Cellectis |
Modifying soybean oil composition through targeted knockout of the fad3a/b/c genes
|
|
WO2017139643A1
(en)
|
2016-02-12 |
2017-08-17 |
University Of Massachusetts |
Anti-angiogenic mirna therapeutics for inhibiting corneal neovascularization
|
|
US20190032088A1
(en)
|
2016-02-26 |
2019-01-31 |
Cellectis |
Micelle based system nuclease encapsulation for in-vivo gene editing
|
|
WO2017153432A1
(en)
|
2016-03-07 |
2017-09-14 |
Pierre Fabre Medicament |
A new universal method to capture and analyze adcs for characterization of drug distribution and the drug-to-antibody ratio in biological samples
|
|
EP3440210A4
(en)
|
2016-04-05 |
2019-11-27 |
University of Massachusetts |
COMPOSITIONS AND METHOD FOR SELECTIVELY INHIBITING THE EXPRESSION OF GRAINYHEAD LIKE PROTEIN
|
|
US11773410B2
(en)
*
|
2016-04-13 |
2023-10-03 |
University Of Massachusetts |
Repairing compound heterozygous recessive mutations by allele exchange
|
|
WO2017181105A1
(en)
|
2016-04-15 |
2017-10-19 |
University Of Massachusetts |
Methods and compositions for treating metabolic imbalance
|
|
DK3452583T3
(da)
|
2016-05-03 |
2022-01-10 |
Prec Biosciences Inc |
Konstruerede nukleaser, der er nyttige til behandling af hæmofili a
|
|
EP4219731A3
(en)
|
2016-05-18 |
2023-08-09 |
Amyris, Inc. |
Compositions and methods for genomic integration of nucleic acids into exogenous landing pads
|
|
CA3021682A1
(en)
|
2016-05-25 |
2017-11-30 |
Cargill Incorporated |
Engineered nucleases to generate deletion mutants in plants
|
|
CN109476715B
(zh)
|
2016-05-26 |
2023-06-27 |
纽海姆有限公司 |
产无籽果实的植物
|
|
CN109640644B
(zh)
|
2016-06-03 |
2021-10-26 |
瑞泽恩制药公司 |
表达外源末端脱氧核苷酸转移酶的非人动物
|
|
WO2017218852A1
(en)
|
2016-06-15 |
2017-12-21 |
University Of Massachusetts |
Recombinant adeno-associated viruses for delivering gene editing molecules to embryonic cells
|
|
US20190359992A1
(en)
|
2016-06-28 |
2019-11-28 |
Cellectis |
Altering expression of gene products in plants through targeted insertion of nucleic acid sequences
|
|
WO2018007263A1
(en)
|
2016-07-06 |
2018-01-11 |
Cellectis |
Sequential gene editing in primary immune cells
|
|
WO2018035141A1
(en)
*
|
2016-08-16 |
2018-02-22 |
Bluebird Bio, Inc. |
Il-10 receptor alpha homing endonuclease variants, compositions, and methods of use
|
|
CA3034271A1
(en)
|
2016-08-18 |
2018-02-22 |
Cellectis |
Black-spot resistant potatoes with reduced tuber-specific polyphenol oxidase activity
|
|
IL264792B2
(en)
|
2016-08-24 |
2023-10-01 |
Sangamo Therapeutics Inc |
Engineered target-specific zinc-finger nucleases
|
|
CA3035484A1
(en)
|
2016-09-01 |
2018-03-08 |
Cellectis |
Methods for altering amino acid content in plants
|
|
US10457940B2
(en)
|
2016-09-22 |
2019-10-29 |
University Of Massachusetts |
AAV treatment of Huntington's disease
|
|
EP3516044B1
(en)
|
2016-09-23 |
2025-04-16 |
Fred Hutchinson Cancer Center |
Tcrs specific for minor histocompatibility (h) antigen ha-1 and uses thereof
|
|
US20190225974A1
(en)
|
2016-09-23 |
2019-07-25 |
BASF Agricultural Solutions Seed US LLC |
Targeted genome optimization in plants
|
|
US11578340B2
(en)
|
2016-10-13 |
2023-02-14 |
University Of Massachusetts |
AAV capsid designs
|
|
WO2018073391A1
(en)
|
2016-10-19 |
2018-04-26 |
Cellectis |
Targeted gene insertion for improved immune cells therapy
|
|
CA3042857A1
(en)
|
2016-11-16 |
2018-05-24 |
Cellectis |
Methods for altering amino acid content in plants through frameshift mutations
|
|
US11192929B2
(en)
|
2016-12-08 |
2021-12-07 |
Regents Of The University Of Minnesota |
Site-specific DNA base editing using modified APOBEC enzymes
|
|
WO2018115189A1
(en)
|
2016-12-21 |
2018-06-28 |
Cellectis |
Stably enginereed proteasome inhibitor resistant immune cells for immunotherapy
|
|
CN118140872A
(zh)
|
2017-01-19 |
2024-06-07 |
欧莫诺艾比公司 |
来自具有多个重链免疫球蛋白基因座的转基因啮齿类动物的人抗体
|
|
MX2019010972A
(es)
|
2017-03-15 |
2019-12-02 |
Hutchinson Fred Cancer Res |
Receptores de linfocito t (tcr) específicos del antígeno asociado a melanoma 1 (mage-a1) de alta afinidad y usos de estos.
|
|
AU2018251150B2
(en)
|
2017-04-13 |
2024-05-09 |
Albert-Ludwigs-Universität Freiburg |
New sequence specific reagents targeting CCR5 in primary hematopoietic cells
|
|
EP3392339A1
(en)
|
2017-04-18 |
2018-10-24 |
Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen |
Improved genome editing in plant cells
|
|
CN110769845B
(zh)
|
2017-04-21 |
2023-08-15 |
精密生物科学公司 |
对pcsk9基因中的识别序列具有特异性的工程化大范围核酸酶
|
|
HUE067206T2
(hu)
|
2017-04-25 |
2024-10-28 |
Cellectis |
Csökkent ligninösszetételû lucerna
|
|
ES2981244T3
(es)
|
2017-04-28 |
2024-10-07 |
Acuitas Therapeutics Inc |
Novedosas formulaciones de nanopartículas de lípidos de carbonilo y lípidos para la administración de ácidos nucleicos
|
|
CA3059793A1
(en)
|
2017-05-03 |
2018-11-08 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (cftr) gene
|
|
US11859179B2
(en)
|
2017-05-09 |
2024-01-02 |
University Of Massachusetts |
Methods of treating amyotrophic lateral sclerosis (ALS)
|
|
WO2018206791A1
(en)
|
2017-05-12 |
2018-11-15 |
Cellectis |
Protease based switch chimeric antigen receptors for safer cell immunotherapy
|
|
CA3064000A1
(en)
|
2017-05-24 |
2018-11-29 |
Effector Therapeutics, Inc. |
Methods and compositions for cellular immunotherapy
|
|
IL270776B2
(en)
|
2017-05-25 |
2024-11-01 |
Bluebird Bio Inc |
Cblb endonuclease variants, compositions, and methods of use
|
|
US20210139870A1
(en)
|
2017-06-19 |
2021-05-13 |
Cellectis |
Anti-hbv combination therapies involving specific endonucleases
|
|
US11332749B2
(en)
|
2017-07-13 |
2022-05-17 |
Regents Of The University Of Minnesota |
Real-time reporter systems for monitoring base editing
|
|
WO2019016360A1
(en)
|
2017-07-21 |
2019-01-24 |
Cellectis |
MODIFIED IMMUNE CELLS RESISTANT TO TUMOR MICRO-ENVIRONMENT
|
|
EP3665191A4
(en)
|
2017-08-11 |
2021-05-05 |
Fred Hutchinson Cancer Research Center |
SPECIFIC BRAF TCRs AND RELATED USES
|
|
EP3678690A1
(en)
|
2017-09-06 |
2020-07-15 |
Fred Hutchinson Cancer Research Center |
Methods for improving adoptive cell therapy
|
|
CA3071661A1
(en)
|
2017-09-06 |
2019-03-14 |
Fred Hutchinson Cancer Research Center |
Strep-tag specific chimeric receptors and uses thereof
|
|
WO2019060686A1
(en)
|
2017-09-22 |
2019-03-28 |
University Of Massachusetts |
NEW DUAL EXPRESSION VECTORS OF SOD1 AND USES THEREOF
|
|
AU2018353112B2
(en)
|
2017-10-19 |
2024-11-14 |
Cellectis |
Targeted gene integration of NK inhibitors genes for improved immune cells therapy
|
|
JP2021502330A
(ja)
|
2017-10-20 |
2021-01-28 |
フレッド ハッチンソン キャンサー リサーチ センター |
Ｔｉｇｉｔおよび／またはｃｄ１１２ｒを標的とするか、またはｃｄ２２６過剰発現を含む、組成物および免疫治療の方法
|
|
EP3704238B1
(en)
*
|
2017-11-01 |
2024-01-03 |
Precision Biosciences, Inc. |
Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a
|
|
WO2019109047A1
(en)
|
2017-12-01 |
2019-06-06 |
Fred Hutchinson Cancer Research Center |
Binding proteins specific for 5t4 and uses thereof
|
|
WO2019106163A1
(en)
|
2017-12-01 |
2019-06-06 |
Cellectis |
Reprogramming of genetically engineered primary immune cells
|
|
JP7104153B2
(ja)
|
2017-12-05 |
2022-07-20 |
プロガストリン、エ、カンセル、エス、アー エル、エル |
癌を治療するための抗プロガストリン抗体と免疫療法の併用療法
|
|
WO2019129850A1
(en)
|
2017-12-29 |
2019-07-04 |
Cellectis |
Off-the-shelf engineered cells for therapy
|
|
WO2019140278A1
(en)
|
2018-01-11 |
2019-07-18 |
Fred Hutchinson Cancer Research Center |
Immunotherapy targeting core binding factor antigens
|
|
BR112020014168A2
(pt)
|
2018-01-12 |
2020-12-08 |
Basf Se |
Proteína, ácido nucleico isolado, gene recombinante, vetor, célula hospedeira, planta, parte de planta ou semente de trigo, métodos para produzir, produto de trigo, farinha, farelo integral, amido, grânulos de amido ou farelo de trigo e métodos para identificar e/ou selecionar uma planta de trigo
|
|
US20210079061A1
(en)
|
2018-02-26 |
2021-03-18 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for cellular immunotherapy
|
|
US20200400675A1
(en)
|
2018-02-27 |
2020-12-24 |
Ecs-Progastrin Sa |
Progastrin as a biomarker for immunotherapy
|
|
US11981892B2
(en)
|
2018-04-16 |
2024-05-14 |
University Of Massachusetts |
Compositions and methods for improved gene editing
|
|
CA3099102C
(en)
|
2018-05-02 |
2024-05-14 |
Cellectis |
Engineering wheat with increased dietary fiber
|
|
US11690921B2
(en)
|
2018-05-18 |
2023-07-04 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
|
IL279271B2
(en)
|
2018-06-07 |
2025-05-01 |
The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo |
Methods for Cannabis Regeneration and Transformation
|
|
CN112424365A
(zh)
|
2018-06-07 |
2021-02-26 |
以色列国家农业部、农村发展农业研究组织·沃尔卡尼中心 |
核酸构建体及其使用方法
|
|
US12163129B2
(en)
|
2018-06-08 |
2024-12-10 |
University Of Massachusetts |
Antisense oligonucleotides to restore dysferlin protein expression in dysferlinopathy patient cells
|
|
EP3806903B1
(en)
|
2018-06-14 |
2024-02-14 |
2seventy bio, Inc. |
Cd79a chimeric antigen receptors
|
|
EP3806619A1
(en)
|
2018-06-15 |
2021-04-21 |
Nunhems B.V. |
Seedless watermelon plants comprising modifications in an abc transporter gene
|
|
CA3105331A1
(en)
|
2018-07-09 |
2020-01-16 |
Cellectis |
Canola with high oleic acid
|
|
WO2020018964A1
(en)
|
2018-07-20 |
2020-01-23 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for controlled expression of antigen-specific receptors
|
|
MX2021000786A
(es)
|
2018-07-20 |
2021-06-15 |
Pf Medicament |
Receptor para supresor de ig del dominio v de activación de células t (vista).
|
|
CA3109496A1
(en)
|
2018-08-22 |
2020-02-27 |
Fred Hutchinson Cancer Research Center |
Immunotherapy targeting kras or her2 antigens
|
|
BR112021003830A2
(pt)
|
2018-08-28 |
2021-07-20 |
Fred Hutchinson Cancer Research Center |
métodos e composições para terapia celular t adotiva incorporando sinalização notch induzida
|
|
JP2022500052A
(ja)
|
2018-09-18 |
2022-01-04 |
サンガモ セラピューティクス， インコーポレイテッド |
プログラム細胞死１（ｐｄ１）特異的ヌクレアーゼ
|
|
IL281615B1
(en)
|
2018-09-21 |
2025-09-01 |
Acuitas Therapeutics Inc |
Systems and methods for producing lipid nanoparticles and liposomes
|
|
US20240165232A1
(en)
|
2018-09-24 |
2024-05-23 |
Fred Hutchinson Cancer Research Center |
Chimeric receptor proteins and uses thereof
|
|
US20220048966A1
(en)
|
2018-09-28 |
2022-02-17 |
Pierre Fabre Medicament |
New immunocytokines for the treatment of cancer
|
|
WO2020072059A1
(en)
|
2018-10-04 |
2020-04-09 |
Bluebird Bio, Inc. |
Cblb endonuclease variants, compositions, and methods of use
|
|
MX2021005308A
(es)
|
2018-11-09 |
2021-09-08 |
Fred Hutchinson Cancer Center Star |
Receptores de celulas t especificos para mesotelina y su uso en inmunoterapia.
|
|
WO2020142598A2
(en)
|
2019-01-04 |
2020-07-09 |
Cargill, Incorporated |
Engineered nucleases to generate mutations in plants
|
|
AU2020205717B2
(en)
|
2019-01-11 |
2025-09-11 |
Acuitas Therapeutics, Inc. |
Lipids for lipid nanoparticle delivery of active agents
|
|
WO2020172332A1
(en)
|
2019-02-20 |
2020-08-27 |
Fred Hutchinson Cancer Research Center |
Binding proteins specific for ras neoantigens and uses thereof
|
|
CN113811607A
(zh)
|
2019-03-07 |
2021-12-17 |
加利福尼亚大学董事会 |
CRISPR-Cas效应子多肽和其使用方法
|
|
WO2020185796A1
(en)
|
2019-03-11 |
2020-09-17 |
Fred Hutchinson Cancer Research Center |
High avidity wt1 t cell receptors and uses thereof
|
|
JP2022536364A
(ja)
|
2019-06-13 |
2022-08-15 |
ザ ジェネラル ホスピタル コーポレイション |
操作されたヒト内在性ウイルス様粒子および細胞への送達のためのその使用方法
|
|
EP3987024A4
(en)
|
2019-06-20 |
2023-11-01 |
University Of Massachusetts |
COMPOSITIONS AND METHODS FOR ENHANCED GENOMIC EDITING
|
|
CN114555790B
(zh)
|
2019-08-20 |
2025-02-25 |
弗雷德哈钦森癌症中心 |
Wt-1特异性t细胞免疫疗法
|
|
EP4025606A1
(en)
|
2019-09-04 |
2022-07-13 |
Y-Biologics Inc. |
Anti-vsig4 antibody or antigen binding fragment and uses thereof
|
|
AU2020350760B2
(en)
|
2019-09-20 |
2024-10-31 |
Cibus Europe B.V. |
Low phytoestrogen soybean based on gene editing
|
|
AU2020391435A1
(en)
|
2019-11-27 |
2022-06-23 |
Cibus Europe B.V. |
Tal-effector nucleases for gene editing
|
|
US20230227559A1
(en)
|
2019-12-10 |
2023-07-20 |
Institut Pasteur |
New antibody blocking human fcgriiia and fcgriiib
|
|
KR20220118532A
(ko)
|
2019-12-23 |
2022-08-25 |
셀렉티스 |
고형 종양들 암 면역요법을 위한 새로운 메소텔린 특이적 키메라 항원 수용체들 (car)
|
|
US20230046668A1
(en)
|
2019-12-24 |
2023-02-16 |
Selexis S.A. |
Targeted integration in mammalian sequences enhancing gene expression
|
|
BR112022014799A2
(pt)
|
2020-01-31 |
2022-09-20 |
Calyxt Inc |
Planta de soja, parte de planta ou célula de planta, método para gerar uma planta de soja e composição de óleo de soja
|
|
EP3889183A1
(en)
|
2020-04-01 |
2021-10-06 |
Pierre Fabre Medicament |
A protein complex comprising an immunocytokine
|
|
EP4146812A1
(en)
|
2020-05-06 |
2023-03-15 |
Cellectis S.A. |
Methods for targeted insertion of exogenous sequences in cellular genomes
|
|
WO2021224416A1
(en)
|
2020-05-06 |
2021-11-11 |
Cellectis S.A. |
Methods to genetically modify cells for delivery of therapeutic proteins
|
|
CA3189338A1
(en)
|
2020-07-16 |
2022-01-20 |
Acuitas Therapeutics, Inc. |
Cationic lipids for use in lipid nanoparticles
|
|
US20230242900A1
(en)
*
|
2020-07-16 |
2023-08-03 |
The Texas A&M University System |
Self-eliminating transgenes
|
|
WO2022018262A1
(en)
|
2020-07-24 |
2022-01-27 |
Cellectis S.A. |
T-cells expressing immune cell engagers in allogenic settings
|
|
WO2022020800A2
(en)
|
2020-07-24 |
2022-01-27 |
The General Hospital Corporation |
Enhanced virus-like particles and methods of use thereof for delivery to cells
|
|
WO2022040582A1
(en)
*
|
2020-08-21 |
2022-02-24 |
Precision Biosciences, Inc. |
Engineered meganucleases having specificity for a recognition sequence in the transthyretin gene
|
|
EP4501951A3
(en)
|
2020-08-25 |
2025-04-30 |
Kite Pharma, Inc. |
T cells with improved functionality
|
|
WO2022066973A1
(en)
|
2020-09-24 |
2022-03-31 |
Fred Hutchinson Cancer Research Center |
Immunotherapy targeting pbk or oip5 antigens
|
|
US20250018036A1
(en)
|
2020-09-24 |
2025-01-16 |
Fred Hutchinson Cancer Center |
Immunotherapy targeting sox2 antigens
|
|
WO2022072718A1
(en)
|
2020-09-30 |
2022-04-07 |
Nobell Foods, Inc. |
Recombinant milk proteins and food compositions comprising the same
|
|
US10947552B1
(en)
|
2020-09-30 |
2021-03-16 |
Alpine Roads, Inc. |
Recombinant fusion proteins for producing milk proteins in plants
|
|
US10894812B1
(en)
|
2020-09-30 |
2021-01-19 |
Alpine Roads, Inc. |
Recombinant milk proteins
|
|
WO2022076353A1
(en)
|
2020-10-06 |
2022-04-14 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for treating mage-a1-expressing disease
|
|
US20230416786A1
(en)
|
2020-11-30 |
2023-12-28 |
Cellectis Sa |
Use of aminoquinoline compounds for higher gene integration
|
|
EP4259651A2
(en)
|
2020-12-14 |
2023-10-18 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
US20240301372A1
(en)
*
|
2021-01-25 |
2024-09-12 |
Fred Hutchinson Cancer Center |
Treatment for hsv-1 using a meganuclease
|
|
BR112023015865A2
(pt)
|
2021-02-09 |
2023-10-31 |
Univ California |
Reguladores imunológicos envolvidos na defesa contra doenças vegetais causadas por espécies de liberibacter
|
|
US20240158503A1
(en)
|
2021-03-03 |
2024-05-16 |
Pierre Fabre Medicament |
Anti-vsig4 antibody or antigen binding fragment and uses thereof
|
|
WO2022190058A1
(en)
|
2021-03-12 |
2022-09-15 |
Dcprime B.V. |
Methods of vaccination and use of cd47 blockade
|
|
US20240197880A1
(en)
|
2021-04-30 |
2024-06-20 |
Cellectis S.A. |
New anti-muc1 cars and gene edited immune cells for solid tumors cancer immunotherapy
|
|
TW202309088A
(zh)
|
2021-04-30 |
2023-03-01 |
法商皮爾法伯製藥公司 |
新的穩定抗ｖｉｓｔａ抗體
|
|
US20240299453A1
(en)
|
2021-05-20 |
2024-09-12 |
Cellectis S.A. |
GENE THERAPY FOR THE TREATMENT OF HYPER-IgE SYNDROME (HIES) BY TARGETED GENE INTEGRATION
|
|
CA3217404A1
(en)
|
2021-05-20 |
2022-11-24 |
Toni CATHOMEN |
Gene therapy for the treatment of severe combined immunodeficiency (scid) related to rag1
|
|
US20250057952A1
(en)
|
2021-05-21 |
2025-02-20 |
Cellectis S.A. |
Enhancing efficacy of t-cell-mediated immunotherapy by modulating cancer-associated fibroblasts in solid tumors
|
|
WO2022272296A2
(en)
|
2021-06-25 |
2022-12-29 |
Homology Medicines, Inc. |
Adeno-associated virus packaging systems
|
|
US20250250319A1
(en)
|
2021-07-15 |
2025-08-07 |
Fred Hutchinson Cancer Center |
Chimeric transmembrane polypeptides comprising a tgf beta receptor extracellular domain, a transmembrane domain and an interleukin receptor 2 intracellular signalling domain and its use in therapy
|
|
CA3228262A1
(en)
|
2021-08-04 |
2023-02-09 |
The Regents Of The University Of Colorado, A Body Corporate |
Lat activating chimeric antigen receptor t cells and methods of use thereof
|
|
US20230090654A1
(en)
|
2021-08-24 |
2023-03-23 |
Homology Medicines, Inc. |
Adeno-associated virus formulations
|
|
US20230183659A1
(en)
|
2021-10-29 |
2023-06-15 |
Homology Medicines, Inc. |
Methods and compositions for the purification of adeno-associated virus
|
|
CA3237482A1
(en)
|
2021-11-03 |
2023-05-11 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Precise genome editing using retrons
|
|
GB202117314D0
(en)
|
2021-11-30 |
2022-01-12 |
Clarke David John |
Cyclic nucleic acid fragmentation
|
|
JP2024544013A
(ja)
|
2021-12-03 |
2024-11-26 |
ザ ブロード インスティテュート，インコーポレーテッド |
有効なｉｎ ｖｉｖｏ送達のための組成物および方法
|
|
WO2023114901A2
(en)
|
2021-12-15 |
2023-06-22 |
Oxford Biomedica Solutions Llc |
Methods and compositions for the production of adeno-associated virus
|
|
WO2023114943A2
(en)
|
2021-12-16 |
2023-06-22 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
WO2023141602A2
(en)
|
2022-01-21 |
2023-07-27 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
|
WO2023213814A1
(en)
|
2022-05-02 |
2023-11-09 |
Pierre Fabre Medicament |
New formulation of anti vista antibody
|
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
EP4276174A1
(en)
|
2022-05-09 |
2023-11-15 |
Cellectis S.A. |
Gene therapy for the treatment of activated pi3kinase delta syndrome type 1 (apds1)
|
|
CN120303407A
(zh)
|
2022-05-17 |
2025-07-11 |
恩维洛普治疗有限责任公司 |
用于有效体内递送的组合物和方法
|
|
AU2023279849A1
(en)
|
2022-06-03 |
2024-12-05 |
Cellectis Sa |
Tale base editors for gene and cell therapy
|
|
AU2023298102A1
(en)
|
2022-06-30 |
2024-11-14 |
Cellectis S.A. |
Enhancing safety of t-cell-mediated immunotherapy
|
|
WO2024044723A1
(en)
|
2022-08-25 |
2024-02-29 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
|
AU2023374658A1
(en)
|
2022-11-03 |
2025-04-24 |
Cellectis S.A. |
Enhancing efficacy and safety of t-cell-mediated immunotherapy
|
|
WO2024121380A1
(en)
|
2022-12-08 |
2024-06-13 |
Pierre Fabre Medicament |
Vaccinal composition and adjuvant
|
|
WO2024209089A1
(en)
|
2023-04-07 |
2024-10-10 |
Commissariat A L'energie Atomique Et Aux Energies Alternatives |
Use of antibody against the endothelin receptor b for diagnostic and therapeutic applications
|
|
AU2024270764A1
(en)
|
2023-05-15 |
2025-12-04 |
Nchroma Bio, Inc. |
Compositions and methods for epigenetic regulation of hbv gene expression
|
|
WO2024236547A1
(en)
|
2023-05-18 |
2024-11-21 |
Inceptor Bio, Llc |
Modified phagocytic cells expressing chimeric antigen receptors comprising a herpes virus entry mediator (hvem) co-stimulatory domain and uses thereof
|
|
WO2024246301A1
(en)
|
2023-06-02 |
2024-12-05 |
Cellectis Sa |
Methods for identifying tale base editors off-sites
|
|
WO2025046513A1
(en)
|
2023-08-29 |
2025-03-06 |
Inceptor Bio, Llc |
Methods of manufacturing myeloid-derived cells from hematopoietic stem cells and compositions and uses thereof
|
|
WO2025054540A1
(en)
|
2023-09-08 |
2025-03-13 |
Iovance Biotherapeutics, Inc. |
Methods of gene-editing using programmable nucleases
|
|
WO2025059215A1
(en)
|
2023-09-12 |
2025-03-20 |
Aadigen, Llc |
Methods and compositions for treating or preventing cancer
|
|
WO2025081123A1
(en)
|
2023-10-12 |
2025-04-17 |
Fred Hutchinson Cancer Center |
Methods and compositions for improving t cell immunotherapy
|
|
WO2025101820A1
(en)
|
2023-11-08 |
2025-05-15 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
WO2025245169A1
(en)
|
2024-05-21 |
2025-11-27 |
Fred Hutchinson Cancer Center |
Immunotherapy cells equipped with a collagen-targeting payload
|